Lonza says in talks to buy Capsugel; deal could top $5 billion: Reuters

Swiss pharmaceutical manufacturer Lonza Group AG on Monday confirmed it is in advanced talks with private equity firm KKR & Co LP to acquire Capsugel, a U.S. maker of capsule products and other drug delivery systems, Reuters reported.

DealsNorth AmericaUSBriefs